BioSpace News Archive

Healthcare technology leader Axxess released a new comprehensive wound care management system that enables users to document and track wound care seamlessly.

Troy-based Jagannathan Neurosurgery is pleased to announce the addition of it’s second board-certified neurosurgeon, Dr. M. Adam Kremer.

TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced the closing of its previously announced underwritten public offering, with total gross proceeds of approximately $15.0 million

ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced the closing of its previously announced registered direct offering of approximately 4,938,278 of the Company’s ordinary shares, at a purchase price of $1.8225 per ordinary share, priced at-the-market under Nasdaq Rules

LabCorp (NYSE: LH) will release its second quarter of 2020 financial results before the market opens on Tuesday, July 28, 2020, and then will host a conference call and webcast beginning at 9:00 a.m. EDT to discuss the results

DLA Piper represented Liquidia Technologies, Inc., a late-stage clinical biopharmaceutical company, in its acquisition of RareGen, LLC, a portfolio company of healthcare investment firm PBM Capital.

Ancestry®, the global leader in family history and consumer genomics, today announced a new, preliminary finding stemming from analysis of Ancestry’s COVID-19 Research Study.

The Coalition for the Advancement of Research and Innovation in Trauma (CARIT) announced today the addition of Prytime Medical Inc. (Prytime).

Sinovac Biotech Ltd. ( “Sinovac” or the “ Company”)(Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced an update to its previously announced partnership with Butantan, a leading Brazilian producer of immunobiologic products and vaccines. On July 3, 2020, the Brazilian National Regulatory Agency, Anvisa, granted approval to a phase III clinical trial sponsored by Instituto Butantan to tes

CardieX Limited (ASX: CDX, CardieX, the Company) 100% subsidiary ATCOR has submitted a US patent application in regards to its recently announced wearable sensor technology (ASX: 24/04/2020).